Gastrointestinal effects are among the most frequently reported adverse events with GLP-1 therapies and typically include nausea, vomiting, diarrhea, constipation, and abdominal pain
(4) Avoiding triggers (fried foods, cream sauces, carbonation, large portions)
Greger also compares these risks with those of obesity
[160] In January 2022, distribution of Lilly's COVID-19 antibody drug was paused due to lack of efficacy against the emerging omicron variant
This means contents, including archaea, are not properly moving through and out of the small intestine, potentially causing an increase in the number of bacteria or archaea (i.e
Current practice in the perioperative management of patients with diabetes mellitus: a narrative review